Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes columnist.

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Experimental treatment ALG-801 was shown to be more effective than approved PAH therapies at reducing signs of disease in an ...

Worldwide, pulmonary arterial hypertension affects more than 2 of every 100,000 women and girls of childbearing age, a new ...

A pulmonary hypertension diagnosis left columnist Jolie Lizana with more grief than she could handle. Now she believes she's ...

Gossamer Bio is moving toward acquiring Respira Therapeutics and its lead treatment candidate, RT234, an inhaled therapy being developed for the on-demand treatment of pulmonary hypertension (PH). The ...

Underweight infants with pulmonary hypertension (PH) are at increased risk of developing retinopathy of prematurity (ROP), a leading cause of childhood blindness, according to a study. However, the ...

“Acceptance doesn’t mean resignation; it means understanding that something is what it is and that there’s got to be a way through it.” — Michael J. Fox For over 10 years, I’ve been navigating life ...